Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: Revisiting the role of surfactants
- 21 October 2006
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 117 (1) , 51-58
- https://doi.org/10.1016/j.jconrel.2006.10.015
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma modelJournal of Microencapsulation, 2006
- Body distribution of polysorbate‐80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in ratsJournal of Drug Targeting, 2005
- Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatographyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Negative preclinical results with stealth® nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor modelJournal of Controlled Release, 2004
- Uptake and transport of high‐density lipoprotein (HDL) and HDL‐associated α‐tocopherol by an in vitro blood–brain barrier modelJournal of Neurochemistry, 2004
- Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticlesInternational Journal of Cancer, 2004
- Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticlesPublished by Elsevier ,2003
- Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain BarrierJournal of Drug Targeting, 2002
- Mechanisms regulating body distribution of nanospheres conditioned with pluronic and tetronic block co-polymersAdvanced Drug Delivery Reviews, 1995
- Characterisation of polybutylcyanoarylate nanoparticles: I. Quantification of PCBA polymer and dextransInternational Journal of Pharmaceutics, 1994